Moreover, a correlation was shown between PHLDA1 overexpression and a negative prognosis in breast, ovary, lung, brain, and cholangiocarcinoma cancers 3) (Figure 2), as analyzed using PrognoScan and the Kaplan–Meier Plotter (Table S4) databases. Here, PHLDA1 is linked to cholangiocarcinoma.